Low endogenous glucocorticoid allows induction of kidney cortical cyclooxygenase-2 during postnatal rat development

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Madsen, Kirsten ^a   Stubbe, Jane ^a   Yang, Tianxin ^b   Skøtt, Ole ^a   Bachmann, Sebastian ^c   Jensen, Boye L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

11 hydroxysteroid dehydrogenase 2; Aldosterone; Mineralocorticoid; Nephrogenesis; Prostaglandin

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; CANRENOATE POTASSIUM; CORTICOSTERONE; CYCLOOXYGENASE 2; DEOXYCORTICOSTERONE ACETATE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR;

ALDOSTERONE BLOOD LEVEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; EMBRYO; ENZYME INDUCTION; FEMALE; HENLE LOOP; HORMONE ACTION; IMMUNOREACTIVITY; KIDNEY CORTEX; KIDNEY DEVELOPMENT; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

EID: 0347990541     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00099.2003     Document Type: Article

References (41)

1. Al-Dahan J, Stimmler L, Chantler C, and Haycock GB. The effect of antanatal dexamethasone addministration on glomerular filtration rate and renal sodium excretion in premature infants. Pediatr Nephrol 1: 131-135, 1987.
2. 2+ channel is localized in rat distal nephron and collecting duct. Am J Physiol Renal Physiol 279: F997-F1005, 2000.
3. + metabolism. Proc Natl Acad Sci USA 95: 9424-9429, 1998.
4. Celsi G, Kistner A, Aizman R, Eklöf AC, Ceccatelli S, De Santiago A, and Jacobson SH. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 44: 317-322, 1998.
5. Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie AJ, and Stewart PM. Expression of type 2 11β-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab 83: 4490-4497, 1998.
6. Dalle M, Giry J, Gay M, and Delost P. Perinatal changes in plasma and adrenal corticosterone and aldosterone concentrations in the mouse. J Endocrinol 76: 303-309, 1978.
7. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contrl NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, and Trazskos JM. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409, 1995.
8. Fischer E, Schnermann J, Briggs JP, Kriz W, Ronco PM, and Bachmann S. Ontogeny of NO synthase and renin in juxtaglomerular apparatus of rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1164-F1176, 1995.
9. Funder JW, Pearce PT, Smith R, and Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988.
10. + exchanger activity during fetal life in sheep. Am J Physiol Renal Fluid Electrolyte Physiol 268: F710-F717, 1995.
11. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, and Breyer MD. Cyclooxygenase II is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 94: 2504-2510, 1994.
12. Henning SJ. Plasma concentrations of total and free corticosterone during development in the rat. Am J Physiol Endocrinol Metab Gastrointest Physiol 235: E451-E456, 1978.
13. Hill KJ, Lumbers ER, and Elbourne I. The actions of cortisol on fetal renal function. J Dev Physiol 10: 85-96, 1988.
14. Inoue H, Umesono K, Nishimori T, Hirata Y, and Tanabe T. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem Biophys Res Commun 254: 292-298, 1998.
15. Jensen BL and Kurtz A. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int 52: 1242-1249, 1997.
16. Jewell CM, Webster JC, Burnstein KL, Sar M, Bodwell JE, and Cidlowski JA. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors. J Steroid Biochem Mol Biol 55: 135-146, 1995.
17. Kalinyak JE, Griffin CA, Hamilton RW, Bradshaw JG, Perlman AJ, and Hoffman AR. Developmental and hormonal regulation of glucocorticoid receptor messenger RNA in the rat. J Clin Invest 84: 1843-1848, 1989.
18. Khan KN, Stanfield KM, Dannenberg A, Seshan SV, Baergen RN, Baron DA, and Soslow RA. Cyclooxygenase-2 expression in the developing human kidney. Pediatr Dev Pathol 4: 461-466, 2001.
19. Koh GY, Nussenzveig DR, Okolicany J, Price DA, and Maack T. Dynamics of atrial natriuretic factor-guanylate cyclase receptors and receptor-ligand complexes in cultured glomerular mesangial and renomedullary interstitial cells. J Biol Chem 267: 11987-11994, 1992.
20. Kömhoff M, Grone HJ, Klein T, Seyberth HW, and Nüsing RM. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol Renal Physiol 272: F460-F468, 1997.
21. Kömhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Harris RC, and Breyer MD. Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57: 414-422, 2000.
22. Merlet-Bernichou C, Gilbert T, Muffat-Joly M, Lelievre-Pegorier M, and Leroy B. Intrauterine growth retardation leads to a permanent nephron deficit in the rat. Pediatr Nephrol 8: 175-180, 1994.
23. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jenette JC, Mahler JF, Klukman KD, Ledford A, Lee CA, and Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473-482, 1995.
24. Nakamura K, Stokes JB, and McCray PB Jr. Endogenous and exogenous glucocorticoid regulation of ENaC mRNA expression in developing kidney and lung. Am J Physiol Cell Physiol 283: C762-C772, 2002.
25. Norregaard R, Uhrenholt TR, Bistrup C, Skott O, and Jensen BL. Stimulation of 11-β hydroxysteroid dehydrogenase type 2 in rat colon but not in kidney by low dietary NaCl intake. Am J Physiol Renal Physiol 285: F348-F358, 2003.
26. Norwood VF, Morham SG, and Smithies O. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney Int 58: 2291-2300, 2000.
27. Odermatt A, Arnold P, and Frey FJ. The intracellular localization of the mineralocorticoid receptor is regulated by 11β-hydroxysteroid dehydrogenase type 2. J Biol Chem 276: 28484-28492, 2001.
28. Ogawa T, Tomomasa T, Hikima A, Kobayashi Y, Nakano K, Fukabori Y, and Morikawa A. Developmental changes in cyclooxygenase mRNA expression in the kidney of rats. Pediatr Nephrol 16: 618-622, 2001.
29. Ortiz LA, Quan A, Weinberg A, and Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney Int 59: 1663-1669, 2001.
30. Schmitt R, Ellison DH, Farrean N, Rossier BC, Rellly RF, Reeves WB, Oberbäumer I, Tapp R, and Bachmann S. Developmental expression of sodium entry pathways in rat nephron. Am J Physiol Renal Physiol 276: F367-F381, 1999.
31. Stubbe J, Jensen BL, Bachmann S, Morsing P, and Skøtt O. Cyclooxygenase-2 contributes to elevated renin in the early postnatal period in rats. Am J Physiol Regul Integr Comp Physiol 284: R1179-R1189, 2003.
32. Todd-Turla KM, Schnermann J, Fejes-Toth G, Naray-Fejes-Toth A, Smart A, Killen PD, and Briggs IP. Distribution of mineralocorticoid and glucocorticoid receptor mRNA along the nephron. Am J Physiol Renal Fluid Electrolyte Physiol 264: F781-F791, 1993.
33. Van den Anker JN, Hop WC, de Groot R, van der Heijden BJ, Broerse HM, Lindemans J, and Sauer PJ. Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant. Pediatr Res 36: 578-581, 1994.
34. Van der Heijden BJ, Carlus C, Narcy F, Bavoux F, Delezoide AL, and Gubler MC. Persistent anuria, neonatal death, and renal microcystic lesions after prenatal exposure to indomethacin. Am J Obstet Gynecol 171: 617-623, 1994.
35. Vio CP, An SJ, Cespedes C, Mcgiff JC, and Ferreri NR. Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy. J Am Soc Nephrol 12: 649-658, 2001.
36. Vio CP, Balestrini C, Recabarran M, and Cespedes C. Postnatal development of cyclooxygenase-2 in the rat kidney. Immunopharmacology 44: 205-210, 1999.
37. Yan K, Kudo A, Hirano H, Watanabe T, Tasaka T, Kataoka S, Nakajima N, Nishibori Y, Shibata T, Kohsaka T, Higashihara E, Tanaka H, Watanabe H, Nagasawa T, and Awa S. Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int 56: 65-73, 1999.
38. Zhang MZ, Hao CM, Breyer MD, Harris RC, and McKanna JC. Mineralocorticoid regulation of cyclooxygenase-2 expression in rat renal medulla. Am J Physiol Renal Physiol 283: F509-F516, 2002.
39. Zhang MZ, Harris RC, and McKanna JA. Regulation of cyclooxygenase-2 (COX-2) in rat renal cortex by adrenal glucocorticoids and mineralocorticoids. Proc Natl Acad Sci USA 96: 15280-15285, 1999.
40. Zhang MZ, Wang JL, Cheng HF, Harris RC, and McKanna JA. Cyclooxygenase-2 in rat nephron development. Am J Physiol Renal Physiol 273: F994-F1002, 1997.
41. Zhang MZ, Wang SW, Cheng H, Zhang Y, McKanna JA, and Harris RC. Regulation of renal cortical cyclooxygenase-2 in young rats. Am J Physiol Renal Physiol 285: F881-F888, 2003.